Cilostazol prevents impairment of slow axonal transport in streptozotocin-diabetic rats

被引:6
|
作者
Yamamoto, Y [1 ]
Yasuda, Y
Komiya, Y
机构
[1] Otsuka Pharmaceut Co Ltd, Inst New Drug Res 1, Tokushima 7710192, Japan
[2] Gunma Univ, Sch Med, Dept Mol & Cellular Neurobiol, Gunma 3718511, Japan
[3] Otsuka Pharmaceut Co Ltd, Pharmaceut Mkt Div, Tokushima 7710192, Japan
关键词
streptozotocin-diabetic; rat; cilostazol; antiplatelet vasodilating agent; phosphodiesterase inhibitor;
D O I
10.1016/S0014-2999(00)00804-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We studied the effects of cilostazol, an antiplatelet and vasodilating agent, on axonal transport patterns of cytoskeletal proteins in the motor fibers of sciatic nerve of streptozotocin-induced diabetic rats. Proteins labeled with L-[S-35]methionine in 6-mm consecutive segments of the nerve were analyzed electrophoretically following fractionation into Triton-soluble and-insoluble subpopulations. Transport rates of proteins (particularly neurofilaments) in slow component a were reduced by 50% 2 weeks after labeling (4 weeks after streptozotocin). An apparent reduction of tubulin and actin was observed at later intervals after induction of diabetes. Actin transported in slow component b was also impaired, though to a lesser extent than in component a. Cilostazol prevented transport impairment of both slow components a and b without affecting hyperglycemia or reduction in body weight gain. These results suggest that in sciatic motor fibers early defects in slowly transported proteins are more marked in slow component a, and that impairment may be caused primarily by hemodynamic abnormalities. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条
  • [21] IMPAIRMENT OF HEPATIC ESTROGEN-RECEPTOR TRANSLOCATION IN STREPTOZOTOCIN-DIABETIC AND FASTED RATS
    LAX, ER
    SCHRIEFERS, H
    ACTA ENDOCRINOLOGICA, 1986, 111 : 153 - 153
  • [22] THE EFFECT OF HYPERLIPIDEMIA ON DIABETIC NEPHROPATHY OF STREPTOZOTOCIN-DIABETIC RATS
    UTSUNOMIYA, K
    OTA, H
    YOSHIZAWA, N
    KURATA, H
    IKEDA, Y
    DIABETES, 1993, 42 : A191 - A191
  • [23] Neurotrophin-3 prevents mitochondrial dysfunction in sensory neurons of streptozotocin-diabetic rats
    Huang, TJ
    Sayers, NM
    Verkhratsky, A
    Fernyhough, P
    EXPERIMENTAL NEUROLOGY, 2005, 194 (01) : 279 - 283
  • [24] Anti-inflammatory effects of lycopene prevents cardiac dysfunction in streptozotocin-diabetic rats
    Li, Wei
    Zhou, Pingping
    Wang, Guoguang
    Lu, Xiaohua
    Jiang, Yuxin
    Zhao, Xue
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (05): : 8047 - 8054
  • [25] Inhibition of accelerated gastric emptying prevents excessive postprandial hyperglycemia in streptozotocin-diabetic rats
    Krowicki, ZK
    Sadowska-Krowicka, HT
    GASTROENTEROLOGY, 2001, 120 (05) : A463 - A463
  • [26] Mangiferin mitigates diabetic cardiomyopathy in streptozotocin-diabetic rats
    Hou, Jun
    Zheng, Dezhi
    Zhong, Guocheng
    Hu, Yonghe
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2013, 91 (09) : 759 - 763
  • [27] ANTIOXIDANT TREATMENT PREVENTS THE DEVELOPMENT OF PERIPHERAL-NERVE DYSFUNCTION IN STREPTOZOTOCIN-DIABETIC RATS
    CAMERON, NE
    COTTER, MA
    MAXFIELD, EK
    DIABETOLOGIA, 1993, 36 (04) : 299 - 304
  • [28] DELAYED AXONAL-TRANSPORT OF CYTOSKELETAL PROTEINS IN STREPTOZOTOCIN DIABETIC RATS
    FIGLIOMENI, B
    MACIOCE, P
    FILLIATREAU, G
    DIGIAMBERARDINO, L
    DIABETOLOGIA, 1987, 30 (07) : A519 - A519
  • [29] DECREASED AXONAL-TRANSPORT OF STRUCTURAL PROTEINS IN STREPTOZOTOCIN DIABETIC RATS
    JAKOBSEN, J
    SIDENIUS, P
    JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (02): : 292 - 297
  • [30] SALIVARY ACINAR LIPID IN STREPTOZOTOCIN-DIABETIC RATS
    GARRETT, JR
    ANDERSON, LC
    JOURNAL OF DENTAL RESEARCH, 1986, 65 (04) : 512 - 512